Live Breaking News & Updates on Harpoon therapeutics inc

Stay informed with the latest breaking news from Harpoon therapeutics inc on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Harpoon therapeutics inc and stay connected to the pulse of your community

Merck Announces First-Quarter 2024 Financial Results

Sales Reflect Continued Strong Growth in Oncology and Vaccines

Total Worldwide Sales Were $15.8 Billion, an Increase of 9% From First Quarter 2023; Excluding the Impact of Foreign Exchange,...

Chicago , Illinois , United-states , Canada , Japan , China , Argentina , Argentine , America , American , Adempas-verquvo , Raludotatug-deruxtecan

Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar

Merck Raises Forecast as Sales of Its Cancer Immune Therapy Soar
bnnbloomberg.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bnnbloomberg.ca Daily Mail and Mail on Sunday newspapers.

Rob-davis , Prometheus-biosciences-inc , Acceleron-pharma-inc , Daiichi-sankyo-co , Bloomberg-merck-co , Harpoon-therapeutics-inc , Daiichi-sankyo , Chief-executive-officer-rob-davis , Acceleron-pharma ,

Industry veteran joins Merck as new EVP, chief HR officer

Industry veteran joins Merck as new EVP, chief HR officer
njbiz.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from njbiz.com Daily Mail and Mail on Sunday newspapers.

United-states , America , Betty-larson , Steve-mizell , Northwestern-university , Baxter-credit-union , Cr-bard-inc , Harpoon-therapeutics-inc , Elanco-animal-health-inc , Ge-healthcare , America-most-responsible-company , Baxter-international

Head-To-Head Comparison: Harpoon Therapeutics (NASDAQ:HARP) vs. LianBio (NASDAQ:LIAN)

Harpoon Therapeutics (NASDAQ:HARP – Get Free Report) and LianBio (NASDAQ:LIAN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, profitability, dividends, analyst recommendations, earnings, institutional ownership and valuation. Profitability This table compares Harpoon Therapeutics and LianBio’s […]

California , United-states , New-jersey , South-san-francisco , China , Abbvie-biotechnology-ltd , Merck-sharp-dohme , Tarsus-pharmaceuticals-inc , Harpoon-therapeutics-inc , Harpoon-therapeutics , Get-free-report

Harpoon Therapeutics, Inc. (NASDAQ:HARP) Receives Average Rating of "Hold" from Brokerages

Shares of Harpoon Therapeutics, Inc. (NASDAQ:HARP – Get Free Report) have received a consensus recommendation of “Hold” from the six analysts that are presently covering the stock, MarketBeat Ratings reports. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The average 1 year […]

United-states , Leerink-partnrs , Northern-trust-corp , Harpoon-therapeutics-inc , Securities-exchange-commission , Citigroup , Sequoia-financial-advisors , Delphia-united-states-inc , Nasdaq , Charles-schwab-investment-management-inc , Merck-co-inc , Harpoon-therapeutics

Ron Hunt: Positions, Relations and Network

Director/Board Member at Rallybio Corp., Discover Ron Hunt's known position history, network and 100 relationships. Find out about his known public assets.

Canada , Stevenage , Hertfordshire , United-kingdom , New-york , United-states , Dublin , Ireland , Cambridge , Cambridgeshire , Waltham , Leicestershire

Merck Completes Acquisition of Harpoon Therapeutics, Inc.

Merck Completes Acquisition of Harpoon Therapeutics, Inc.
pharmiweb.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pharmiweb.com Daily Mail and Mail on Sunday newspapers.

United-states , Canada , Merck-co-inc , Statement-of-merck-co-inc , Youtube , Instagram , Facebook , Nasdaq , Merck-research-laboratories , Exchange-commission , Drug-administration

Merck Completes Acquisition of Harpoon Therapeutics, Inc.

Acquisition broadens oncology pipeline with a portfolio of novel T-cell engagers including HPN328 , an investigational delta-like ligand 3 targeting T-cell engager

...

Canada , United-states , Merck-co-inc , Youtube , Instagram , Facebook , Drug-administration , Merck-research-laboratories , Harpoon-therapeutics-inc , Linkedin , Statement-of-merck-co-inc

Merck Acquires Harpoon Therapeutics

The additional products will bolster its oncology portfolio.

Merck-animal-health , Elanco-animal-health-inc , Merck-research-laboratories , Drug-administration , Harpoon-therapeutics-inc , Merck-research , Orphan-drug-designation , Animal-health , Elanco-animal-health ,

Merck Completes Acquisition Of Harpoon Therapeutics

Merck (MRK) announced the completion of the acquisition of Harpoon Therapeutics, Inc. (HARP). Harpoon is now a wholly-owned subsidiary of the company. Harpoon's common stock will no longer be publicly traded or listed on the Nasdaq Stock Market.

Harpoon-therapeutics-inc , More-such-health-news , Harpoon-therapeutics , Nasdaq-stock , Merck , Arpoon-therapeutics ,